← Back to all trials
Not Yet Recruiting
NCT06895187
Catheter Ablation Using a Novel Navigation and Imaging System
Conditions: Paroxysmal Atrial Fibrillation
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: LUMA Vision Ltd.
Summary
The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).
Eligibility Criteria
Inclusion Criteria:
* Subject is 18 years of age at the time of consent, or of legal age to give informed consent specific to state and national law
* Subjects is eligible for a catheter ablation procedure with the VERAFEYE System as navigation and imaging system in the treatment of PAF (according to VERAFEYE System IFUs, current international and local guidelines and per physician discretion)
* Subject is able to understand and willing to provide written informed consent
* Subject is able to and willing to complete all study assessments associated with this clinical study at an approved clinical investigational center
Exclusion Criteria:
Source: ClinicalTrials.gov (NCT06895187). StuddyBuddy aggregates publicly available trial information.
